1. Home
  2. CTKB vs EMD Comparison

CTKB vs EMD Comparison

Compare CTKB & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • EMD
  • Stock Information
  • Founded
  • CTKB 1990
  • EMD 2003
  • Country
  • CTKB United States
  • EMD United States
  • Employees
  • CTKB N/A
  • EMD N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EMD Finance/Investors Services
  • Sector
  • CTKB Health Care
  • EMD Finance
  • Exchange
  • CTKB Nasdaq
  • EMD Nasdaq
  • Market Cap
  • CTKB 708.8M
  • EMD 576.8M
  • IPO Year
  • CTKB 2021
  • EMD N/A
  • Fundamental
  • Price
  • CTKB $6.52
  • EMD $9.70
  • Analyst Decision
  • CTKB Strong Buy
  • EMD
  • Analyst Count
  • CTKB 2
  • EMD 0
  • Target Price
  • CTKB $9.25
  • EMD N/A
  • AVG Volume (30 Days)
  • CTKB 620.3K
  • EMD 248.5K
  • Earning Date
  • CTKB 11-05-2024
  • EMD 01-01-0001
  • Dividend Yield
  • CTKB N/A
  • EMD 10.25%
  • EPS Growth
  • CTKB N/A
  • EMD N/A
  • EPS
  • CTKB N/A
  • EMD N/A
  • Revenue
  • CTKB $201,210,000.00
  • EMD N/A
  • Revenue This Year
  • CTKB $8.18
  • EMD N/A
  • Revenue Next Year
  • CTKB $11.15
  • EMD N/A
  • P/E Ratio
  • CTKB N/A
  • EMD N/A
  • Revenue Growth
  • CTKB 9.88
  • EMD N/A
  • 52 Week Low
  • CTKB $4.66
  • EMD $7.85
  • 52 Week High
  • CTKB $9.87
  • EMD $9.55
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 50.58
  • EMD 44.15
  • Support Level
  • CTKB $6.04
  • EMD $9.63
  • Resistance Level
  • CTKB $6.55
  • EMD $9.85
  • Average True Range (ATR)
  • CTKB 0.32
  • EMD 0.13
  • MACD
  • CTKB -0.04
  • EMD -0.03
  • Stochastic Oscillator
  • CTKB 42.35
  • EMD 34.58

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About EMD Western Asset Emerging Markets Debt Fund Inc

Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management investment company. Its primary investment objective is to seek high current income and the secondary objective is to seek capital appreciation.

Share on Social Networks: